1. Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics
   D. Flodrova et al, 2017, Toxicology Letters CrossRef
2. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion
   Junhee Park et al, 2019 CrossRef
3. The role of prostate tumor overexpressed 1 in cancer progression
   Verónica Cánovas et al, 2017, Oncotarget CrossRef
4. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts
   Raoud Marayati et al, 2021, Translational Oncology CrossRef
5. Effects of polyclonal activators on cell differentiation and cytokine production of cultured invasive breast carcinoma of no special type, their association with tumour histopathological parameters and lymph node metastasis
   Alexander Autenshlyus et al, 2020, Int J Immunopathol Pharmacol CrossRef
6. Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy
   Mohamed R. Abdelaal et al, 2021, Molecules CrossRef
7. An Updated Comprehensive Review on Vitamin A and Carotenoids in Breast Cancer: Mechanisms, Genetics, Assessment, Current Evidence, and Future Clinical Implications
   Jee Ah Kim et al, 2021, Nutrients CrossRef
8. The Role of ATRA, Natural Ligand of Retinoic Acid Receptors, on EMT-Related Proteins in Breast Cancer: Minireview
   Pavel Bobal et al, 2021, IJMS CrossRef
9. Antioxidants in brain tumors: current therapeutic significance and future prospects
   Xuchen Qi et al, 2022, Mol Cancer CrossRef
10. ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer Cells
    Akira Hirota et al, 2022, Cancers CrossRef
11. Pan-cancer Analysis Confirms the Prognostic and Immunological Effects of Prostate Tumor Overexpressed-1 in Human Cancers
    Fashun Liu et al, 2024, CCDT CrossRef